Fredrik Ellin

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

Journal: British journal of haematology

Published: May 03, 2026

Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-up.

Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 11, 2024

Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up.

Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up.

Journal: HemaSphere

Published: July 11, 2024

Limited stage mantle cell lymphoma: A real-world study of primary treatment and prognosis in Sweden 2006-2018.

Limited stage mantle cell lymphoma: A real-world study of primary treatment and prognosis in Sweden 2006-2018.

Journal: HemaSphere

Published: May 23, 2024

The National Swedish Lymphoma Register - a systematic validation of data quality.

The National Swedish Lymphoma Register - a systematic validation of data quality.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 27, 2024

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

Journal: Blood advances

Published: January 29, 2024

Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients.

Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients.

Journal: European journal of haematology

Published: May 15, 2023

Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project.

Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project.

Journal: HemaSphere

Published: March 10, 2023

Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group.

Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group.

Journal: American journal of hematology

Published: May 23, 2022

Burkitt Lymphoma International Prognostic Index.

Burkitt Lymphoma International Prognostic Index.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 27, 2021

Impact of comorbidity in older patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients.

Impact of comorbidity in older patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients.

Journal: Blood advances

Published: January 14, 2021

Is the CNS-PINK the new CNS risk model in ENKTL?

Is the CNS-PINK the new CNS risk model in ENKTL?

Journal: Blood

Published: November 26, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026